Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee endorses time-limited veterans PTSD research trial with legislative guardrails (HB 390)
Summary
The committee favorably recommended first substitute HB 390 to authorize a tightly scoped, time-limited clinical research trial on psychedelic-assisted therapy for treatment-resistant PTSD among veterans, with oversight by FDA, DEA and an institutional review board; veterans and researchers testified in strong support.
The Health and Human Services Committee on Feb. 19 favorably recommended first substitute HB 390, which would authorize a tightly scoped, time-limited clinical research trial to study psychedelic-assisted therapy for treatment-resistant post-traumatic stress disorder (PTSD) in veterans.
Retired Lt. Col. Matthew Butler, a veteran, gave emotional testimony describing personal recovery after seeking psychedelic-assisted care abroad. “I can say with absolute certainty that I owe my life, my happiness, my sobriety, my happy…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
